In the past week, DeSci has once again become a hot topic of discussion. After Binance Labs announced its investment in BIO Protocol, tokens in the DeSci field such as VITA, GROW, and RSC have seen significant price increases, and have maintained strong performance even as the broader market has pulled back. The previously low-key BIO Genesis event was immediately filled, and the "pump" small experiment platform previously launched by the BIO team has also been "revived". It seems that all the hot crypto money is now flowing into DeSci.
The "revived" official small experiment
The meme market has remained hot, and from various narrative angles, the DeSci meme coins RIF and URO have seen 20-fold increases in value in less than two days. These two tokens come from the Pump.science platform and represent the compounds rifampicin (RIF) and uric acid (URO).
Pump.science is a meme token issuance platform launched by the DeSci project Molecule DAO, using meme coins to support medical experiments. The RIF and URO tokens did not generate much hype when they were launched, with a market cap of around $150,000. But in the past few days, RIF and URO have continuously hit new highs, with their market cap reaching as high as $3 million, a 20-fold increase.
Pump.Science was launched by the DeSci platform Molecule DAO at the Token 2049 Solana Breakpoint conference this year as a meme token issuance platform, where players can purchase meme tokens representing drugs and participate in predicting drug effects and trading experimental data. See related reading: "The DeSci leader also gets creative, can Pump.science play the 'biotech meme' well?" The "revival" of Pump.science in these past few days can be said to be inseparable from Binance's frequent moves in the DeSci field.
On November 8, Binance Labs announced an investment in BIO Protocol, stating that this investment marks Binance Labs' first foray into the decentralized science (DeSci) field. Less than a week after this announcement, CZ attended Binance's DeSci Day event in Bangkok and discussed DeSci insights with Vitalik.
Regarding BIO Protocol, it can be learned that it focuses on the medical research field, using blockchain technology to change the financing and commercialization of early-stage scientific research. BIO Protocol founder Paul Kohlhaas has stated that BIO Protocol is committed to breaking the traditional scientific research funding dilemma and promoting patient-driven global research, bringing revolutionary changes.
At the DeSci Day event in Bangkok, Vtalik Buterin also showed CZ the first longevity product of VitaDAO - VD001, a natural high-dose spermidine supplement that has received Thai FDA approval. CZ directly stated that "I hope to see 1,000 DeSci projects next year".
It was also in these past few days that the prices of various DeSci project tokens have risen significantly. In addition to the RIF and URO mentioned at the beginning of the article, the VitaDAO token VITA and the ResearchCoin token RSC of the DeSci project have also seen impressive gains.
The favorite track of crypto big shots?
In fact, DeSci has always had a high "reputation".
As early as last year, the DeSci concept had sparked a wave of enthusiasm in the Chinese community, and DeSci's innovations in longevity research had attracted CZ's attention. He had stated that he has always been paying attention to biotechnology and thinking about how to use crypto technology to accelerate the flow of research funding in this field, and this post also became a key point in the resurgence of DeSci.
Not only CZ, but at the DeSci conference held in Berlin last year, there were also many industry leaders who participated, such as Zee Prime Capital co-founder Matti and Molecule CEO Tyler Golato, who actively shared their research and insights on DeSci and had high expectations for the DeSci field.
More than a month ago, a16z also made its first foray into the DeSci field, leading the investment in AminoChain, a DeSci project dedicated to reforming the patient contribution of biological samples in the medical field. Binance has also repeatedly revealed on social media that it is ready to use blockchain technology to strongly support scientific projects, and CZ has stated that "innovation often occurs in small groups, and we need decentralized science because many excellent researchers cannot get enough funding."
It can be foreseen that under the drive of Binance, the DeSci field will attract more and more attention.
Which projects can you follow?
The BIO Protocol, which received investment from Binance Labs, aims to build a global research funding and collaboration platform based on blockchain and DAO, hoping to use blockchain technology to help solve currently intractable problems in rare diseases, longevity research, and emerging health issues. The BIO Protocol network currently has seven BIO DAOs covering areas such as cryopreservation, women's health, and mental health. The protocol token BIO and the tokens of its cooperative DAOs can be used as investment targets.
BIO (BIO Protocol)
On August 9, BIO Protocol launched its first round of Bio Genesis token sales, with an average price of $0.025 and a trading volume of $115.1 million. The second round of token sales was held on September 30, with the average price of BIO already up 72% to $0.043, and the trading volume also increased to $194.9 million. By the time of the 2.5th round of public auction on November 10, the price of BIO had risen to $0.066, an increase of 264% from the first round. The auction rounds of BIO Protocol have now been completed.
VITA (VitaDAO)
VitaDAO is a group focused on funding early-stage longevity research, with fundraising exceeding $5 million and receiving investment from Pfizer Ventures. Since Vitalik showed CZ the first VitaDAO product VD001 in Bangkok, VITA has entered a bull run mode, with a single-day high of 82.4%, and the latest price is $3.12, with a market cap exceeding $80 million, nearly tripling in the past week.
RSC (ResearchHub)
RSC is the native token of the ResearchHub platform, which was founded by Coinbase founder Brian Armstrong and is mainly used to reward users who publish high-quality content (new papers, comments, peer reviews, and paper highlights) on the platform. Whenever a user publishes such content or receives upvotes, they will receive a certain amount of RSC tokens, and the number of RSC can represent the user's reputation on the ResearchHub platform, with higher reputation granting greater power (the ability to mark, edit or delete low-quality content to ensure the quality of content on the platform).
ResearchHub also has a cooperative relationship with BIO protocol, and the RSC has seen a nearly 200% increase in the past week, with its market cap reaching $60 million for the first time in six months.
In addition, the dynamics of the Pump.science platform tokens RIF and URO, as well as its incubator Molecule DAO, mentioned at the beginning of the article, are also worth following.
However, a review of the token history reveals that RSC saw a nearly 40-fold monthly increase in November 2023, followed by a significant decline; VITA also reached a market capitalization of around $100 million in 2022 and 2023 before falling back. Whether this Binance Labs backing and CZ and Vitalik's passionate "shilling" can propel the Desci track to new heights remains to be seen.
Welcome to join the official BlockBeats community:
Telegram subscription group: https://t.me/theblockbeats
Telegram discussion group: https://t.me/BlockBeats_App
Twitter official account: https://twitter.com/BlockBeatsAsia
